OUR PUBLICATIONS 

arrow&v

2022

Funders’ Perspectives on Supporting Implementation Research in Low- and Middle-Income Countries

Cardoso-Weinberg A, Alley C, Kupfer LE, Aslanyan G, Makanga M, Zicker F, Olesen OF

Glob Health Sci Pract. 2022;10(2):e2100497.

2022

A gaps-and-needs analysis of vaccine R&D in Europe: Recommendations to improve the research infrastructure

Jungbluth S, Depraetere H, Slezak M, Christensen D, Stockhofe N, Beloeil LA

Biologicals. 2022 Feb 26:S1045-1056(22)00017-3.

2021

Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain

Bekeredjian-Ding I, Trouvin JH, Depraetere H, La C, Suvarnapunya AE, Bell A, Mann A, Meij P, Bethony JM, Schellhaas L, Nazziwa WB, Karikari-Boateng E, Prachumsri JS, Salmikangas P, Smith D, Stjärnkvist P, Van Molle W, Baay M, Neels P

Biologicals. 2021 Nov;74:16-23.

2021

Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses

Remarque EJ, Faber BW, Rodriguez Garcia R, Oostermeijer H, Sirima SB, Ouedraogo IN, Kara L, Launay O, Houard S, Leroy O, and Kocken CHM

npj Vaccines 2021 6: 55

2021

Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses

Remarque EJ, Faber BW, Rodriguez Garcia R, Oostermeijer H, Sirima SB, Nebie Ouedraogo I, Kara L, Launay O, Houard S, Leroy O, Kocken CHM

NPJ Vaccines. 2021 Apr 14;6(1):55.

2021

Progress and Insights Toward an Effective Placental Malaria Vaccine

Gamain B, Chêne A, Viebig NK, Tuikue Ndam N, Nielsen MA.

Front Immunol. 2021 Feb 25;12:634508.

2020

Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities

Akkermans A, Chapsal JM, Coccia EM, Depraetere H, Dierick JF, Duangkhae P, Goel S, Halder M, Hendriksen C, Levis R, Pinyosukhee K, Pullirsch D, Sanyal G, Shi L, Sitrin R, Smith D, Stickings P, Terao E, Uhlrich S, Viviani L, Webster J.

iologicals. 2020 Nov;68:92-107.

2020

PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.

Sirima SB, Richert L, Chêne A, Konate AT, Campion C, Dechavanne S, Semblat JP, Benhamouda N, Bahuaud M, Loulergue P, Ouédraogo A, Nébié I, Kabore M, Kargougou D, Barry A, Ouattara SM, Boilet V, Allais F, Roguet G, Havelange N, Lopez-Perez E, Kuppers A, Konaté E, Roussillon C, Kanté M, Belarbi L, Diarra A, Henry N, Soulama I, Ouédraogo A, Esperou H, Leroy O, Batteux F, Tartour E, Viebig NK, Thiebaut R, Launay O, Gamain B.

Lancet Infect Dis. 2020 May;20(5):585-597.

2020

Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A.

Geiger KM, Guignard D, Yang C, Bikorimana JP, Correia BE, Houard S, Mkindi C, Daubenberger CA, Spertini F, Corradin G, Audran R.

Front Immunol. 2020 Mar 10;11:412.

2019

Editorial: A Global Perspective on Vaccines: Priorities, Challenges and Online Information.

Tagliabue A, Leite LCC, Leroy OY, Rappuoli R.

Front Immunol. 2019 Nov 12;10:2556.